| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.024 | 0.9 |